≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Adhesive middle ear disease

DOID EFO Endpoint Browser PheWeb

H8_MIDDLEADDH

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H74.1
  • Hospital discharge: ICD-9 — 3851
  • Cause of death: ICD-10 — H74.1
  • Cause of death: ICD-9 — 3851

2 out of 7 registries used, show all original rules.

629

4. Check minimum number of events

None

629

5. Include endpoints

None

629

6. Filter based on genotype QC (FinnGen only)

629

Control definitions (FinnGen only)

Control exclude
H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H74
Name in latin
Morbus adhaesivus auris mediae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7161 3318 3824
Only index persons 6710 3122 3588
Unadjusted period prevalence (%)
Whole population 0.10 0.10 0.11
Only index persons 0.13 0.11 0.14
Median age at first event (years)
Whole population 23.56 31.19 16.81
Only index persons 23.60 31.18 17.00

-FinnGen-

Key figures

All Female Male
Number of individuals 629 349 280
Unadjusted period prevalence (%) 0.12 0.12 0.12
Median age at first event (years) 41.89 39.86 44.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
566
Matched controls
5661
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
323.0
528
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
688.2
235.7
217
5
H65.3
ICD-10 Finland
Chronic mucoid otitis media
431.3
187.3
178
6
UDC00
NOMESCO Finland
Ear microscopy
24.8
157.0
233
155
H71
ICD-10 Finland
Cholesteatoma of middle ear
+∞
131.5
121
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
771.6
128.8
122
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
17.3
106.6
178
146
Z01.1
ICD-10 Finland
Examination of ears and hearing
10.5
103.5
231
350
4122
FHL
Tympanostomy (tympanic tube)
263.3
89.3
89
*
H65.2
ICD-10 Finland
Chronic serous otitis media
+∞
86.7
81
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
79.0
74
*
H66.9
ICD-10 Finland
Otitis media, unspecified
12.5
69.1
131
133
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
45.0
63.6
78
20
DFF00
NOMESCO Finland
Pure tone audiometry
9.4
63.1
141
193
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
59.6
62.7
73
14
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
4.4
56.6
294
1125
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
186.4
49.7
51
*
DCD00
NOMESCO Finland
Myringoplasty
+∞
49.7
47
*
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
46.9
48.6
59
14
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
33.6
48.3
63
21
DC1AD
NOMESCO Finland
Temporalbone CT
55.2
46.7
55
11
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
+∞
46.5
44
*
DGW00
NOMESCO Finland
Dilatation of eustachian tube
+∞
46.5
44
*
3851A
ICD-9 Finland
Other disorders of middle ear and mastoid, Adhesive middle ear disease
+∞
43.3
41
*
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
97.6
41.4
45
5
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
116.1
40.3
43
*
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
414.9
39.6
39
*
DCD10
NOMESCO Finland
Tympanoplasty
+∞
36.9
35
*
EMB30
NOMESCO Finland
Adenotomy
10.5
34.4
69
74
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.3
33.0
139
399
H65.0
ICD-10 Finland
Acute serous otitis media
23.7
32.3
46
21
S02CA02
ATC
flumetasone and antiinfectives; otic
7.1
30.6
78
124
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
32.1
29.8
39
13
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
84.7
29.1
32
*
4451
FHL
Guitar cutting
11.0
28.9
56
56
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
28.4
27
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
6.7
27.4
73
123
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
29.5
27.0
36
13
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
+∞
26.2
25
*
H60.8
ICD-10 Finland
Other otitis externa
10.4
24.3
48
50
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
+∞
23.1
22
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.4
22.7
335
2114
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
+∞
22.0
21
*
1450
FHL
Otomicroscopy
62.5
21.0
24
*
DEB20
NOMESCO Finland
Attico-antro-mastoidectomy and tympanotomy
+∞
21.0
20
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
6.9
20.9
53
83
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
11.9
20.8
38
34
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
28.3
20.2
27
10
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
+∞
19.9
19
*
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
+∞
19.9
19
*
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
206.9
19.7
20
*
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
+∞
18.9
18
*
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
+∞
18.9
18
*
DEA10
NOMESCO Finland
Attico-antrotomy
+∞
18.9
18
*
Z3229
NOMESCO Finland
Other healthcare associate professional
3.9
18.4
81
234
H60.9
ICD-10 Finland
Otitis externa, unspecified
4.3
18.1
70
180
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
+∞
17.8
17
*
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
+∞
17.8
17
*
TDA90
NOMESCO Finland
Removal wax from ear
14.5
17.5
29
21
R01AD08
ATC
fluticasone; nasal
2.4
17.3
186
962
DFF15
NOMESCO Finland
Speech audiometry
6.5
17.2
45
74
H69.0
ICD-10 Finland
Patulous Eustachian tube
+∞
16.7
16
*
H60.3
ICD-10 Finland
Other infective otitis externa
9.9
16.6
33
35
DAX08
NOMESCO Finland
Fitting of hearing aid
6.4
16.2
43
72
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
+∞
15.7
15
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.9
15.3
43
78
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
46.3
15.1
18
*
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
+∞
14.6
14
*
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
+∞
14.6
14
*
H66
ICD-10 Finland
Suppurative and unspecified otitis media
7.9
14.6
33
44
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
5.6
14.4
42
80
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
43.7
14.2
17
*
H04
ICPC
Ear discharge
7.5
13.7
32
45
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
+∞
13.6
13
*
J35.2
ICD-10 Finland
Hypertrophy of adenoids
6.2
13.5
36
61
DEB30
NOMESCO Finland
Radical mastoidectomy
143.3
13.5
14
*
4742A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Adenoid vegetations
7.6
12.6
29
40
R01AD09
ATC
mometasone; nasal
1.9
12.6
263
1754
H72.1
ICD-10 Finland
Attic perforation of tympanic membrane
+∞
12.5
12
*
H73.1
ICD-10 Finland
Chronic myringitis
+∞
12.5
12
*
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
+∞
12.5
12
*
H95.0
ICD-10 Finland
Recurrent cholesteatoma of postmastoidectomy cavity
132.8
12.5
13
*
DCB10
NOMESCO Finland
Freeing of adhesions of middle ear
132.8
12.5
13
*
J01DA01
ATC
[U] cefalexin; systemic
1.9
12.3
350
2597
R01BA52
ATC
pseudoephedrine, combinations; oral
2.1
12.2
161
892
J01DA06
ATC
[U] cefuroxime; systemic
2.6
12.2
97
421
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.9
12.0
78
300
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
3.0
11.1
65
234
ZXA10
NOMESCO Finland
Bilateral
2.3
10.9
109
531
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.6
10.9
49
145
H01
ICPC
Ear pain/earache
2.6
10.6
82
350
4141
FHL
Myringoplasty (also for reasons other than inflammation)
112.0
10.5
11
*
DCW00
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
+∞
10.4
10
*
J01DA08
ATC
[U] cefaclor; oral
2.3
10.4
105
510
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
16.4
10.4
16
10
H69.8
ICD-10 Finland
Other specified disorders of Eustachian tube
33.2
10.4
13
*
J01CA04
ATC
amoxicillin; systemic
2.1
10.2
475
4056
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
5.1
9.7
30
62
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
+∞
9.4
9
*
Z96.2
ICD-10 Finland
Presence of otological and audiological implants
+∞
9.4
9
*
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
+∞
9.4
9
*
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
+∞
9.4
9
*
UDC10
NOMESCO Finland
Tympanoscopy
+∞
9.4
9
*
J01FA10
ATC
azithromycin; systemic
1.7
9.4
343
2651
H61.2
ICD-10 Finland
Impacted cerumen
3.6
9.2
41
121
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
4.4
8.9
31
73
H02
ICPC
Hearing complaint
2.6
8.7
65
270
H92.0
ICD-10 Finland
Otalgia
3.2
8.5
43
140
R5120
NOMESCO Finland
Preparation of an aid
6.4
8.4
21
34
4151
FHL
Reoperation for chronic otitis media
+∞
8.4
8
*
DDD10
NOMESCO Finland
Interposition between malleus and stapes
+∞
8.4
8
*
J01DB01
ATC
cefalexin; oral
1.8
8.2
451
3861
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
11.9
8.1
14
12
H02AB06
ATC
prednisolone; systemic
1.7
7.8
235
1683
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
45.6
7.7
9
*
H71
ICPC
Acute otitis media/myringitis
7.6
7.7
17
23
J01FA09
ATC
clarithromycin; systemic
1.8
7.7
173
1133
R5140
NOMESCO Finland
Monitoring the use of the aid
2.6
7.7
55
222
ZXC10
NOMESCO Finland
Use of laser
5.1
7.7
23
47
DCA30
NOMESCO Finland
Exploration of middle ear
81.1
7.4
8
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.4
7.4
60
263
4147
FHL
Radical surgery, cavity filling and middle ear and / or eardrum plastic
+∞
7.3
7
*
4144
FHL
Mastoidectomy or aticomastoidectomy
+∞
7.3
7
*
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
4.5
7.2
24
55
J35.1
ICD-10 Finland
Hypertrophy of tonsils
4.7
7.0
22
48
R4135
NOMESCO Finland
Rehabilitation for hearing problems
6.8
6.9
16
24
SPAT1263
SPAT
Sampling
1.6
6.8
240
1771
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
6.7
143
919
H61.8
ICD-10 Finland
Other specified disorders of external ear
8.8
6.6
13
15
SPAT1301
SPAT
No procedures
1.7
6.5
179
1236
J01MA02
ATC
ciprofloxacin; systemic
1.6
6.5
188
1315
H13
ICPC
Plugged feeling ear
1.9
6.5
92
514
H72
ICD-10 Finland
Perforation of tympanic membrane
70.6
6.4
7
*
H60.4
ICD-10 Finland
Cholesteatoma of external ear
18.3
6.3
9
5
H73.8
ICD-10 Finland
Other specified disorders of tympanic membrane
+∞
6.3
6
*
H74.3
ICD-10 Finland
Other acquired abnormalities of ear ossicles
+∞
6.3
6
*
4145
FHL
Tympanomastoidectomy, includes possible tympanoplasty
+∞
6.3
6
*
Q35.1
ICD-10 Finland
Cleft hard palate
+∞
6.3
6
*
TDC10
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
+∞
6.3
6
*
3810A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media
+∞
6.3
6
*
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
+∞
6.3
6
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.0
6.3
33
113
H91.9
ICD-10 Finland
Hearing loss, unspecified
3.4
6.2
28
86
J01FF01
ATC
clindamycin; systemic
1.7
6.1
131
841
J20
ICD-10 Finland
Acute bronchitis
2.3
6.1
54
248

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
160
531
3.70
40.72
1.9
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
105
507
2.29
12.21
7.5
6.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
174
2.84
9.47
1.9
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
48
189
2.67
8.62
1.9
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
99
571
1.87
6.97
1.4
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
91
520
1.88
6.59
4.5
4.0
%
31.4
31.5
0.04
54
339
(3013512) EKG study
176
1235
1.59
6.02
4.3
3.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
44
204
2.24
5.61
2.8
3.4
—
—
—
0
0
(3019225) pH of Specimen
70
387
1.91
5.60
3.5
4.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
62
335
1.94
5.31
2.8
2.3
ug/l
5.1
7.7
0.80
50
299
(3042936) Bacteria identified in Isolate by Culture
104
660
1.69
5.26
1.8
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
220
1687
1.47
4.80
3.8
3.5
ng/l
28.9
36.6
0.61
151
1076
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
418
3620
1.46
4.72
6.3
7.3
u/l
76.3
78.2
0.41
389
3379
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
506
4572
1.55
4.48
4.4
4.1
mmol/l
5.9
5.8
0.81
449
4183
(3024561) Albumin [Mass/volume] in Serum or Plasma
240
1901
1.42
4.31
3.6
5.0
g/l
35.5
36.1
0.79
222
1778
(3019550) Sodium [Moles/volume] in Serum or Plasma
541
4979
1.62
4.25
14.3
14.1
mmol/l
139.7
139.6
0.59
528
4829
(3023103) Potassium [Moles/volume] in Serum or Plasma
541
4991
1.60
4.06
14.2
14.2
mmol/l
4.0
4.0
0.01
528
4830
(40761535) Cells panel - Urine sediment
60
353
1.77
3.97
3.7
3.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
155
1147
1.47
3.96
3.3
3.0
ng/l
1012.9
1151.4
0.36
125
955
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
139
2.22
3.89
1.2
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
48
269
1.85
3.73
4.3
6.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
109
759
1.53
3.73
1.6
1.7
nmol/l
1251.3
1216.0
0.13
71
568
(3013707) Erythrocyte sedimentation rate by Westergren method
407
3580
1.39
3.71
4.2
3.8
mm/h
11.7
10.8
0.66
370
3296
(3013826) Glucose [Moles/volume] in Serum or Plasma
329
2803
1.36
3.63
3.8
4.7
mmol/l
6.9
6.6
0.93
300
2569
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
19
74
2.62
3.58
1.4
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
47
268
1.81
3.47
3.0
3.5
mmol/l
1.1
1.7
0.42
35
189
(40761511) CBC panel - Blood by Automated count
566
5319
1.64
3.46
13.3
11.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
423
3766
1.38
3.44
3.8
3.8
pmol/l
14.8
14.7
0.50
375
3402
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
101
2.33
3.40
1.5
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
146
1100
1.43
3.34
3.7
3.8
kg/l
1.0
1.0
0.06
19
152
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
54
2.82
3.27
1.7
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
54
2.82
3.27
1.7
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
54
2.82
3.27
1.7
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
387
3413
1.35
3.25
4.0
4.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
102
722
1.49
3.22
1.7
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
55
2.77
3.17
1.7
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
55
2.77
3.17
1.7
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
188
1495
1.37
3.11
2.8
2.6
u/l
51.1
56.1
1.85
172
1381
(3026493) Urate [Moles/volume] in Serum or Plasma
144
1097
1.41
3.08
2.6
2.6
umol/l
10206.0
6588.1
0.29
124
956
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
467
4257
1.38
3.06
5.8
5.2
mmol/mol
39.8
39.1
0.73
420
3972
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
216
1761
1.35
3.03
1.8
1.9
pmol/l
97.5
95.7
0.22
113
901
(3032080) INR in Blood by Coagulation assay
216
1764
1.34
2.99
8.6
8.3
inr
1.4
1.2
1.65
54
560
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
562
5306
1.56
2.96
9.4
9.5
u/l
28.5
26.7
0.90
539
5123
(40758558) Short blood count panel - Blood
89
1232
0.68
2.95
5.2
6.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
150
1160
1.38
2.93
5.0
4.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
16
65
2.50
2.81
1.2
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
42
2.89
2.76
1.1
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
42
2.89
2.76
1.1
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
42
2.89
2.76
1.1
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
146
1.96
2.74
1.2
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
152
1193
1.36
2.70
3.7
3.5
mg/l
981.0
110.3
0.71
85
789
(4010399)
46
283
1.67
2.66
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
55
2.58
2.63
1.7
1.5
—
—
—
0
0
(3020891) Body temperature
30
163
1.88
2.62
6.6
3.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
96
1282
0.70
2.59
3.2
2.8
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
7
7.19
2.55
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
7
7.19
2.55
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
7
7.19
2.55
1.0
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
177
1437
1.32
2.49
3.1
3.2
mmol/l
8.1
7.9
0.18
147
1216
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
16
4.41
2.48
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
16
4.41
2.48
1.0
1.1
—
—
—
0
0
(4146454)
11
40
2.78
2.38
3.1
3.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
230
1945
1.29
2.38
3.7
3.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
17
4.15
2.36
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
156
1257
1.32
2.30
4.3
4.3
mg/mmol
8.1
9.9
0.25
96
819
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
47
2.58
2.28
1.6
1.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
18
3.92
2.25
1.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
532
5025
1.38
2.25
13.7
12.6
mg/l
24.1
22.8
0.38
445
3886
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
712
0.65
2.23
3.1
2.7
e6/l
2.0
2.6
0.28
36
373
(3026008) Bacteria identified in Urine by Culture
173
1420
1.30
2.22
3.1
2.9
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
9
5.59
2.21
1.0
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
54
2.44
2.21
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
36
2.81
2.21
1.8
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
24
3.36
2.18
1.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
24
3.36
2.18
1.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
24
3.36
2.18
1.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
24
3.36
2.18
1.0
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
141
1733
0.76
2.18
3.4
3.4
e6/l
102.7
80.7
0.16
112
1197
(3000475) Leukocytes [#/volume] in Synovial fluid
19
95
2.03
2.12
1.6
1.5
e6/l
8479.6
15631.6
0.52
14
72
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
68
2.24
2.12
2.1
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
511
4809
1.33
2.11
4.5
4.3
mmol/l
2.7
2.8
0.23
465
4449
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
37
2.73
2.11
1.8
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
275
2404
1.26
2.10
4.9
6.2
umol/l
9.5
11.2
5.00
259
2264
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
504
4739
1.32
2.06
4.2
4.0
mmol/l
4.5
4.6
0.99
461
4410
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
56
2.35
2.06
1.5
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
78
574
1.41
2.04
1.9
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
37
564
0.63
1.96
2.0
2.9
umol/l
6.3
8.5
0.51
29
479
(3024731) MCV [Entitic volume]
591
5716
1.56
1.94
19.7
18.2
fl
90.2
90.3
0.12
581
5640
(3035941) MCH [Entitic mass]
591
5717
1.56
1.92
19.7
18.2
pg
30.1
30.2
0.06
581
5640
(3026361) Erythrocytes [#/volume] in Blood
591
5717
1.56
1.92
19.8
18.3
e12/l
4.6
4.5
0.39
578
5565
(3002179) Metamyelocytes/100 leukocytes in Blood
51
351
1.49
1.90
3.2
4.1
%
0.6
0.4
0.44
13
82
(3033658) Prothrombin time (PT) actual/Normal
91
1168
0.74
1.89
2.9
3.8
%
92.1
91.4
0.10
84
1135
(3000963) Hemoglobin [Mass/volume] in Blood
591
5721
1.55
1.86
19.9
18.4
g/l
136.9
136.3
0.47
581
5640
(3010813) Leukocytes [#/volume] in Blood
591
5721
1.55
1.86
19.9
18.3
e9/l
6.9
6.7
1.61
579
5562
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
149
1228
1.28
1.84
5.0
4.7
ug/l
2.2
2.4
0.25
127
1092
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
48
329
1.50
1.83
2.5
2.3
u/l
5533.7
4402.4
0.14
14
142
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
117
936
1.31
1.81
1.6
1.7
pmol/l
189796352.7
17436327.7
0.69
98
780
(3023520) Reticulocytes [#/volume] in Blood
49
339
1.48
1.79
1.8
3.0
e9/l
61.9
68.1
0.78
40
258
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
121
974
1.30
1.79
4.3
4.2
%
19.9
21.1
0.37
53
436
(3029937) Albumin [Presence] in Urine by Test strip
161
1344
1.27
1.79
3.8
3.8
estimate
0.0
0.0
0.50
43
501
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
482
4533
1.27
1.78
3.9
3.6
mmol/l
1.3
1.2
1.42
438
4188
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
499
4714
1.28
1.77
4.3
3.9
mmol/l
1.4
1.4
3.23
453
4373
(1761482) Bacteria [#/volume] in Urine by Culture
21
117
1.82
1.76
4.5
4.1
—
—
—
0
0
(4062490)
10
41
2.46
1.76
1.2
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
117
1436
0.77
1.75
3.1
3.0
e6/l
16.6
97.9
1.13
99
1108
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
18
3.35
1.75
1.0
2.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
18
3.35
1.75
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
18
3.35
1.75
1.3
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
18
3.35
1.75
1.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
18
3.35
1.75
1.0
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
154
1284
1.26
1.72
1.7
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
228
0.47
1.72
2.1
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
406
4351
0.81
1.72
12.6
15.5
%
13.6
13.5
0.43
399
4277
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
47
0.00
1.71
0.0
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
589
5710
1.50
1.69
19.9
18.3
e9/l
254.1
251.3
0.46
577
5569
(3021440) Promyelocytes/100 leukocytes in Blood
52
370
1.44
1.66
3.4
4.1
%
0.1
0.1
0.50
16
108
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
19
3.18
1.66
1.0
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
19
3.18
1.66
1.0
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
224
1955
1.23
1.65
2.1
2.3
nmol/l
73.6
74.6
0.21
192
1760
(3000492) Spirometry study
31
471
0.64
1.64
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
47
329
1.46
1.64
2.8
2.7
e9/l
4.4
4.0
0.56
29
274
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
247
2180
1.22
1.63
5.5
6.6
mmol/l
1.2
1.2
0.12
196
1839
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
153
1285
1.25
1.60
2.2
2.0
u/l
220.3
307.9
0.37
140
1213
(3021960) Folate [Moles/volume] in Serum or Plasma
126
1035
1.27
1.59
1.4
1.5
nmol/l
19.6
20.7
0.33
107
887
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
20
3.02
1.58
1.2
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
160
1.65
1.58
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
481
4545
1.25
1.57
4.7
4.5
mu/l
1.8
2.1
0.56
431
4173
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
153
1.66
1.55
1.2
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
178
1526
1.23
1.55
2.3
3.3
mmol/l
2.4
2.4
0.69
155
1345
(3017181) Myelocytes/100 leukocytes in Blood
54
393
1.41
1.54
3.3
4.0
%
0.8
0.9
0.11
19
117
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
32
209
1.56
1.54
2.6
3.9
%
0.7
0.7
0.03
32
203
(3001604) Monocytes [#/volume] in Blood
274
2454
1.21
1.54
5.3
5.9
e9/l
0.6
0.6
0.95
246
2149
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
15
3.35
1.52
1.0
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
27
170
1.61
1.51
3.5
7.4
%
1.0
0.9
0.39
22
157
(3014271) Vancomycin [Susceptibility]
6
21
2.87
1.51
3.8
2.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
201
2286
0.82
1.49
8.6
9.0
e9/l
0.0
0.0
0.69
175
1877
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
137
1149
1.25
1.45
2.0
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
49
355
1.41
1.45
3.3
4.1
%
0.0
0.0
0.99
16
90
(3022217) INR in Platelet poor plasma by Coagulation assay
67
512
1.35
1.44
26.1
21.7
inr
1.4
1.2
0.57
23
75
(3024354) Oxygen [Partial pressure] in Venous blood
50
364
1.41
1.44
3.5
3.7
kpa
4.1
4.5
1.44
50
352
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.4
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
274
2467
1.20
1.42
5.4
5.9
e9/l
0.0
0.0
0.63
246
2162
(3023511) Choriogonadotropin [Units/volume] in Urine
28
181
1.57
1.42
1.4
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
56
417
1.38
1.42
5.2
8.3
%
95.8
95.7
0.05
51
400
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
11
53
2.09
1.39
2.2
2.7
mg/l
18.6
25.3
—
5
13
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
248
0.55
1.39
1.9
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
248
0.55
1.39
1.9
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
248
0.55
1.39
1.9
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
248
0.55
1.39
1.9
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
144
1223
1.23
1.36
3.3
4.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
17
2.96
1.36
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
17
2.96
1.36
1.4
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
369
3423
1.19
1.34
3.1
3.1
u/l
44.4
41.8
0.32
345
3216
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
206
0.53
1.32
1.9
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
21
129
1.65
1.31
6.2
3.7
mmol/l
3.9
3.9
0.04
21
117
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
41
0.00
1.31
0.0
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
24
2.51
1.30
1.7
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
204
0.53
1.28
1.8
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
204
0.53
1.28
1.8
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
280
2547
1.18
1.25
5.3
5.9
e9/l
2.0
1.9
0.65
253
2278
(3021447) Carbon dioxide [Partial pressure] in Venous blood
56
427
1.34
1.24
3.6
4.3
kpa
6.1
5.8
2.27
56
412
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
108
1.69
1.23
1.9
2.6
ug/min
582.8
58.9
0.59
11
65
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
33
463
0.70
1.22
3.9
3.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
98
808
1.25
1.22
1.3
1.2
iu/ml
14.5
30.3
3.08
39
246
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
60
465
1.32
1.20
5.1
7.9
kpa
5.1
5.1
0.04
54
443
(3027801) Oxygen [Partial pressure] in Arterial blood
60
465
1.32
1.20
5.1
7.9
kpa
11.1
12.4
1.41
55
443
(3021788) Differential panel - Synovial fluid
12
64
1.89
1.18
1.2
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
253
2291
1.17
1.18
3.8
4.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
50
2.02
1.17
1.2
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
93
767
1.25
1.16
1.2
1.3
u/ml
3.9
10.8
1.56
35
314
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
20
2.51
1.15
2.2
2.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
270
0.62
1.15
1.8
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
36
0.00
1.14
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
36
0.00
1.14
0.0
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
278
2549
1.16
1.09
5.7
6.2
e9/l
0.2
0.2
0.05
251
2269
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
32
2.20
1.08
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
32
2.20
1.08
1.1
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
19
289
0.65
1.07
1.1
1.2
—
5.2
—
0
5
(3003458) Phosphate [Moles/volume] in Serum or Plasma
71
574
1.27
1.06
3.6
5.9
mmol/l
1.0
1.0
0.11
60
528
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
252
0.63
1.05
1.1
1.3
—
—
—
0
0
(4034850)
23
154
1.51
1.05
12.6
10.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
58
459
1.29
1.02
5.2
8.0
mmol/l
1.2
1.2
0.04
44
362
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
223
0.62
0.98
1.9
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
308
2863
1.15
0.97
8.0
9.1
e9/l
4.5
4.1
1.88
283
2510
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
31
0.00
0.96
0.0
1.4
—
85.0
—
0
6
(3004588) Protein electrophoresis panel - Serum or Plasma
34
251
1.37
0.96
2.3
2.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
85
1.66
0.95
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
85
1.66
0.95
1.7
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
266
2451
1.15
0.95
3.6
3.4
estimate
0.0
0.0
0.00
42
503
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
10
172
0.57
0.94
2.2
3.9
u/ml
16.4
584.4
—
10
143
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
109
1.58
0.94
1.6
1.3
—
—
—
0
0
(4198724)
7
37
1.90
0.94
2.1
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
144
0.55
0.94
1.1
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
52
1.74
0.92
1.8
1.7
pg
31.9
32.0
—
9
52
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
63
1.76
0.90
1.4
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
59
477
1.26
0.90
1.6
3.2
%
1.7
1.7
0.05
46
432
(3000330) Specific gravity of Urine by Test strip
29
211
1.39
0.90
3.8
3.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
15
229
0.65
0.89
1.5
2.7
u/ml
21.2
35.5
1.03
15
220
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
42
1.92
0.89
1.0
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
114
1305
0.85
0.88
3.0
2.9
e6/l
0.2
0.5
3.44
96
976
(3021879) Hepatitis B virus core Ab [Presence] in Serum
38
490
0.76
0.87
1.3
1.5
—
—
—
0
0
(44813793)
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
(4024509)
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
64
1.73
0.86
1.4
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
129
1458
0.86
0.85
1.9
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
144
1613
0.86
0.84
1.5
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
45
1.79
0.84
1.4
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
57
1.77
0.84
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
111
0.54
0.84
1.3
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
51
411
1.26
0.81
2.3
2.1
nmol/l
11.7
13.8
1.17
46
377
(3023419) Bacteria identified in Sputum by Culture
8
48
1.68
0.79
2.1
2.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
39
305
1.30
0.78
3.6
3.9
ng/l
109.8
75.6
0.65
32
276
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
74
1.63
0.78
1.3
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
123
0.56
0.78
1.0
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
63
753
0.82
0.78
2.7
2.5
e6/l
1.5
1.0
0.51
51
408
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
333
1.28
0.77
2.5
2.4
ml/min/173m2
72.0
66.4
0.47
21
135
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
28
0.00
0.76
0.0
2.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
28
0.00
0.76
0.0
2.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
105
1195
0.85
0.76
1.7
1.6
mmol/l
1.4
1.4
0.09
89
1009
(3030981) Hyaline casts [#/volume] in Urine by Automated count
32
245
1.32
0.75
2.0
2.9
e6/l
0.4
0.2
0.41
32
236
(3048689) Calprotectin [Mass/mass] in Stool
84
721
1.19
0.75
2.3
2.8
ug/g
179.9
141.4
0.30
63
566
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
54
1.68
0.74
4.6
4.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
266
2482
1.12
0.74
3.7
3.5
estimate
0.0
0.0
0.50
40
493
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
24
176
1.38
0.73
1.7
1.7
nmol/l
31.4
39.0
1.79
24
169
(21494890) Protein electrophoresis panel - 24 hour Urine
7
38
1.85
0.73
3.4
2.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
106
0.56
0.73
1.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
39
1.80
0.72
2.9
2.9
—
—
—
0
0
(3044889) 12 lead EKG panel
299
3168
0.89
0.72
3.9
3.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
84
1.56
0.72
1.0
1.0
u/ml
1.4
12.8
—
5
22
(3017569) Oxygen content in Arterial blood
5
26
1.93
0.70
1.6
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
26
1.93
0.70
2.0
2.8
u/ml
1660.6
903.3
—
5
26
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
187
1.35
0.69
1.6
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
27
1.86
0.68
2.2
3.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
42
1.67
0.68
1.1
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
41
504
0.80
0.67
1.4
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
119
1328
0.87
0.67
3.3
3.9
ph
7.4
7.4
0.35
28
252
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
40
322
1.26
0.67
1.1
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
78
1.55
0.66
1.3
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
165
1509
1.13
0.64
2.1
2.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
211
0.70
0.63
1.1
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
79
1.53
0.63
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
217
1.30
0.63
3.0
2.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
261
2453
1.11
0.62
4.9
4.7
estimate
0.0
0.0
0.50
44
511
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
10
63
1.60
0.62
1.2
2.6
mmol/l
4.1
4.0
—
10
63
(3035285) Chloride [Moles/volume] in Venous blood
10
63
1.60
0.62
1.2
2.6
mmol/l
104.3
106.1
—
10
63
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
96
1.47
0.62
5.8
3.7
e9/l
5.1
4.0
0.56
14
96
(3035880) pH of Pleural fluid
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
119
1071
1.14
0.60
1.4
1.8
mg/l
0.8
1.2
1.80
81
799
(3037522) Nuclear Ab [Titer] in Serum
76
662
1.17
0.59
1.4
1.3
titre
596.0
465.8
0.21
20
135
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
44
364
1.22
0.59
3.4
3.5
mmol/l
1.2
1.2
0.29
39
315
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
473
4592
1.12
0.59
10.1
11.5
ml/min/173m2
87.2
87.4
0.07
399
3694
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
72
1.54
0.59
1.0
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
114
1.41
0.59
1.4
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
353
0.78
0.58
1.2
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
55
1.46
0.56
1.4
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
124
0.64
0.55
4.0
3.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
99
1.42
0.54
6.1
4.1
%
58.4
55.5
0.28
14
99
(21494434) Karyotype in Bone marrow
6
38
1.58
0.54
1.0
1.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
38
1.58
0.54
18.5
21.0
nmol/l
1369.8
1441.2
—
6
38
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
62
1.46
0.53
1.3
1.3
nmol/l
0.7
0.5
—
9
57
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
63
1.43
0.52
1.2
2.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
83
1.45
0.52
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
111
1005
1.13
0.52
2.3
2.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
211
1982
1.10
0.50
5.3
6.0
mmol/l
1.2
1.2
0.17
182
1790
(3045424) Erythrocytes [Presence] in Urine
10
67
1.50
0.50
1.3
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
290
1.22
0.48
1.5
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
88
790
1.13
0.48
2.3
2.9
mmol/l
2.4
2.4
0.22
75
684
(3025941) Bacteria identified in Stool by Culture
36
300
1.21
0.47
1.6
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
164
1.29
0.47
2.6
3.6
g/l
0.4
0.3
—
6
72
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
85
1.42
0.47
1.3
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
85
1.42
0.47
1.4
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
120
1.34
0.46
1.3
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
466
4772
0.91
0.46
11.3
13.3
%
40.6
40.3
0.31
288
3672
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
82
0.61
0.46
2.0
2.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
32
384
0.82
0.46
5.3
7.0
mmol/l
1.3
1.4
0.29
32
359
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
42
491
0.85
0.46
1.6
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
121
0.66
0.45
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
108
1180
0.90
0.45
1.6
1.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
7
50
1.40
0.45
1.1
1.2
mu/l
12.4
39.0
—
7
43
(3000991) Gas panel - Venous blood
42
359
1.18
0.44
4.7
7.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
31
1.62
0.43
1.0
1.2
mmol/l
2.5
1.8
—
5
31
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
118.0
—
0
10
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.3
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
134.2
—
0
12
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
18
141
1.28
0.40
1.4
2.2
ug/l
199.7
638.0
0.74
18
130
(3000850) Epithelial cells [#/volume] in Urine
92
1007
0.90
0.40
2.5
2.5
e6/l
6.5
5.6
0.19
81
880
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(4035726)
32
378
0.84
0.40
1.3
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
103
0.68
0.39
1.1
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
81
734
1.12
0.39
1.4
1.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.1
—
94.4
—
0
5
(3047189) Immunofixation for 24 hour Urine
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
0
19
0.00
0.39
0.0
2.7
—
134.4
—
0
9
(3027944) Amphetamines [Presence] in Urine
34
398
0.85
0.39
2.5
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
129
1200
1.09
0.38
2.1
2.2
mg/l
3.0
3.0
0.15
111
1037
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
37
1.35
0.37
1.8
2.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
116
0.69
0.37
1.1
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
89
969
0.91
0.36
3.0
2.6
mosm/kgh2o
566.3
560.4
0.07
80
828
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
126
1.28
0.35
1.3
1.4
ug/g
305.1
306.1
—
10
69
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
44
1.37
0.34
1.8
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
28
237
1.19
0.34
1.3
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
389
3789
1.07
0.34
3.2
3.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
35
403
0.86
0.34
2.5
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
118
1.28
0.33
1.3
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
52
464
1.13
0.33
2.0
1.8
nmol/l
372.7
381.0
0.10
46
423
(3027008) Opiates [Presence] in Urine
35
402
0.86
0.33
2.5
1.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
86
0.69
0.33
1.0
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
86
0.69
0.33
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
17
209
0.81
0.32
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
47
1.28
0.32
2.8
2.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
83
1.33
0.32
4.4
5.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
160
1684
0.93
0.30
3.5
3.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
83
897
0.91
0.30
1.6
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
33
377
0.87
0.30
2.5
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
35
397
0.87
0.29
2.5
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
27
232
1.17
0.29
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
291
0.85
0.29
2.9
2.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
121
1.25
0.28
3.7
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
27
312
0.86
0.28
1.6
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
94
1.28
0.28
4.5
2.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
116
0.77
0.27
1.4
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
15
122
1.24
0.27
1.0
1.5
mg/l
479.5
402.1
0.53
15
116
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
36
319
1.14
0.27
1.4
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
95
1.27
0.26
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
95
1.27
0.26
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
71
0.70
0.26
1.0
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
75
0.66
0.26
1.0
1.0
—
1.3
—
0
14
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
9
72
1.25
0.25
1.1
1.1
g/l
1.4
1.5
—
9
65
(40768800) Prostate Pathology biopsy report
9
72
1.25
0.25
1.2
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
54
493
1.10
0.25
1.5
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
52
566
0.91
0.23
1.2
1.3
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
5
39
1.28
0.23
1.0
1.1
mg/l
282.4
273.4
—
5
34
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
40
1.25
0.22
1.0
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
79
842
0.93
0.22
2.9
3.4
ng/l
65.3
571.5
2.25
44
605
(3016018) Differential panel - Cerebral spinal fluid
5
41
1.22
0.22
1.0
2.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
26.6
—
0
11
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
3.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
5.6
—
0
10
(3007566) Smooth muscle Ab [Titer] in Serum
18
154
1.17
0.21
1.2
1.3
—
54.7
—
0
15
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
103
0.77
0.21
2.5
5.1
—
462.6
—
0
14
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.5
—
16.0
—
0
12
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
13
0.00
0.21
0.0
11.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.1
—
0.8
—
0
7
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.7
—
3897.4
—
0
7
(42529406) Shigella sp [Presence] in Stool by Culture
15
176
0.85
0.20
1.4
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
22
193
1.14
0.20
1.4
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
50
1.20
0.19
3.7
3.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
73
776
0.93
0.19
1.4
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
64
599
1.08
0.19
2.3
2.3
%
18.9
23.8
2.49
52
523
(40761536) Microorganisms panel - Urine sediment
43
467
0.91
0.19
3.3
3.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
54
580
0.92
0.19
1.2
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
111
1161
0.95
0.18
1.4
1.4
g/l
2.3
2.3
0.10
76
717
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
242
1.12
0.18
1.2
1.3
miu/ml
168.0
260.7
1.04
15
122
(3044941) Cell count panel - Synovial fluid
7
58
1.21
0.18
1.1
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
1.0
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
68
640
1.07
0.18
2.3
2.3
g/l
2.4
2.3
0.49
63
594
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
34
310
1.10
0.18
2.4
3.5
pmol/l
5.1
4.7
0.23
29
276
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
142
0.84
0.17
4.0
1.9
g/l
7.1
7.4
—
5
110
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
142
0.84
0.17
4.0
1.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
76
719
1.06
0.17
3.1
2.8
ug/l
0.8
0.8
0.18
48
447
(3001019) Free T4 and TSH panel - Serum or Plasma
23
257
0.89
0.17
1.0
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
113
1084
1.05
0.16
4.2
3.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
114
1095
1.05
0.16
2.4
2.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
78
0.77
0.15
2.3
3.2
u/ml
21.7
58.3
—
6
71
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
78
0.77
0.15
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
317
0.91
0.15
2.5
2.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
171
0.87
0.15
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
171
0.87
0.15
1.4
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
20
223
0.89
0.14
1.5
1.4
iu/l
19.3
18.9
0.02
20
187
(3041096) Erythrocytes [Presence] in Urine by Automated
150
1456
1.04
0.14
3.0
3.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
98
0.81
0.13
1.3
5.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
99
0.81
0.13
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
55
520
1.06
0.13
1.3
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
66
628
1.06
0.13
1.1
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
117
0.85
0.13
4.6
3.4
u/ml
0.4
0.3
—
5
62
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
106
0.85
0.13
1.8
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
174
1782
0.97
0.12
2.6
2.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
30
278
1.08
0.12
2.7
2.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
136
1323
1.04
0.11
1.3
1.3
u/ml
0.7
1.2
1.71
42
352
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
86
1.17
0.11
2.3
2.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
136
0.88
0.11
1.1
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
192
1.10
0.11
1.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.2
mg/l
33.6
37.5
—
5
37
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
5
48
1.04
0.09
1.4
1.3
—
322.7
—
0
11
(3045142) Bone marrow Pathology biopsy report
5
48
1.04
0.09
1.0
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
235
2385
0.98
0.09
5.6
5.7
%
58.5
56.9
1.34
221
2247
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
50
522
0.95
0.09
1.8
1.9
—
—
—
0
0
(4306422)
7
64
1.09
0.08
1.1
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
64
1.09
0.08
1.7
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
162
1591
1.02
0.08
5.8
6.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
70
0.86
0.07
1.7
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
72
0.83
0.07
1.3
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
143
0.91
0.07
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
8
77
1.04
0.07
1.1
2.1
—
1666.7
—
0
6
(3049717) Cytology report of Urine Cyto stain
14
153
0.91
0.07
2.9
2.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
85
0.82
0.07
3.9
2.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
255
1.06
0.07
1.4
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
34
356
0.95
0.06
1.4
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
99
1.11
0.06
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
102
0.88
0.06
1.3
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
72
701
1.03
0.06
2.7
3.4
mmol/l
0.8
0.8
0.20
66
651
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
129
1.09
0.05
1.1
1.1
u/ml
0.2
2.5
—
5
55
(3002030) Lymphocytes/100 leukocytes in Blood
239
2414
0.98
0.05
6.1
5.9
%
27.8
28.4
0.37
226
2265
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
23
219
1.05
0.04
1.4
1.7
mg/l
3.5
3.3
0.06
13
151
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
62
634
0.98
0.04
2.1
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
170
1.06
0.04
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
210
0.95
0.03
6.3
11.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
45
440
1.02
0.02
1.2
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
232
2334
0.99
0.02
2.8
2.7
ug/l
122.1
105.6
0.47
215
2159
(3022096) Basophils/100 leukocytes in Blood
225
2237
1.01
0.02
6.0
6.0
%
0.6
0.7
0.43
208
2094
(3044290) Cell count panel - Cerebral spinal fluid
10
93
1.08
0.02
1.0
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
177
0.96
0.01
1.6
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
38
387
0.98
0.01
1.2
1.2
iu/ml
83.3
147.9
1.12
17
151
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
104
1.06
0.01
3.2
3.9
mg/l
25.8
30.2
—
6
66
(3006504) Eosinophils/100 leukocytes in Blood
232
2313
1.00
0.00
5.9
5.9
%
2.5
2.8
1.76
217
2157
(3013139) Helicobacter pylori Ag [Presence] in Stool
29
284
1.02
0.00
1.2
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
14
145
0.96
0.00
2.0
3.3
g/l
4.6
3.6
—
9
138
(4094501)
11
106
1.04
0.00
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
124
0.97
0.00
1.0
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
183
0.98
0.00
1.5
2.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
10
99
1.01
0.00
1.7
4.3
umol/l
30.9
37.4
—
10
85
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
101
0.99
0.00
1.0
1.2
—
1.0
—
0
7
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
42
418
1.01
0.00
3.2
4.5
ug/l
25.0
41.0
0.29
31
349
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
49
488
1.00
0.00
1.4
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
163
1633
1.00
0.00
3.1
3.4
u/l
30.7
31.7
0.15
156
1551
(40768804) Tissue Pathology biopsy report
184
1843
1.00
0.00
2.0
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
87
872
1.00
0.00
1.4
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
23
231
1.00
0.00
1.6
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
233
2329
1.00
0.00
6.3
6.2
%
8.3
8.4
0.27
219
2192
(40757373) Influenza virus identified in Isolate
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
52
0.96
0.00
1.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
17.6
—
0
8
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
19.4
—
0.4
—
0
8
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
21.3
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
9.7
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
14.1
—
0
6
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
9.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44790047)
5
57
0.88
0.00
1.2
1.4
—
—
—
0
0
(44790049)
5
57
0.88
0.00
1.2
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
6
64
0.94
0.00
1.0
1.4
—
10.6
—
0
9
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
89
0.90
0.00
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
76
0.92
0.00
1.6
1.5
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
19.6
—
0
5
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
72
0.97
0.00
1.3
1.2
u/l
12.4
25.7
—
7
61
(3022229) Phosphate [Moles/volume] in Urine
0
5
0.00
0.00
0.0
5.8
—
12.7
—
0
5
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
190
1.00
0.00
1.8
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
6.6
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
2.0
—
0
7
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
94
0.96
0.00
1.1
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
6
0.00
0.00
0.0
7.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
88
0.91
0.00
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
92
0.98
0.00
1.2
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.0
—
0
5
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
4.8
—
9.7
—
0
6
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
6.7
—
15.0
—
0
7
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(44806118)
5
57
0.88
0.00
1.2
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44790048)
5
57
0.88
0.00
1.2
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_MIDDLEADDH and mortality.

Females

Parameter HR [95% CI] p-value
H8_MIDDLEADDH 1.106 [0.97, 1.26] 0.133
Birth year 0.997 [0.99, 1.01] 0.534

During the follow-up period (1.1.1998 — 31.12.2019), 364 out of 2840 females with H8_MIDDLEADDH died.

Males

Parameter HR [95% CI] p-value
H8_MIDDLEADDH 0.981 [0.85, 1.13] 0.785
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 343 out of 3211 males with H8_MIDDLEADDH died.

Mortality risk

Mortality risk for people of age

years, who have H8_MIDDLEADDH.

N-year risk Females Males
1 0.124% 0.176%
5 0.686% 1.216%
10 1.732% 2.881%
15 3.336% 5.368%
20 5.743% 8.851%

Relationships between endpoints

↥

Index endpoint: H8_MIDDLEADDH – Adhesive middle ear disease

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data